Cogent Biosciences, Inc.
COGT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001622229
In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Cogent Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 69 | 1 | 73 | +5 |
| Shares | 36.4M | 20.0K | 36.8M | +428.2K (+1.2%) |
| Value | $293.7M | $162.0K | $309.6M | +$16.1M (+5.5%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Cogent Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vivo Capital, LLC | 1,420,941 | $11.9M | 0.54% |
| Marshall Wace North America L.P. | 327,332 | $2.75M | 0.01% |
| Goldman Sachs Group Inc | 149,693 | $1.26M | 0.00% |
| Bank of Montreal | 131,757 | $1.16M | 0.00% |
| Franklin Resources Inc | 54,500 | $458.0K | 0.00% |
| SG Americas Securities, LLC | 19,307 | $162.0K | 0.00% |
| Citadel Advisors LLC | 14,340 | $121.0K | 0.00% |
| MetLife Investment Management | 14,022 | $117.9K | 0.00% |
| Capstone Investment Advisors, LLC | 12,928 | $109.0K | 0.00% |
| Trexquant Investment LP | 11,407 | $96.0K | 0.01% |
| Metropolitan Life Insurance Co | 10,609 | $89.2K | 0.00% |
| Red Tortoise LLC | 342 | $5.00K | 0.00% |
| UBS Group AG | 258 | $2.00K | 0.00% |
| FMR LLC | 87 | $1.00K | 0.00% |
Sold out (9)
Institutions that held Cogent Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,000,000 | $8.11M |
| Tekla Capital Management LLC | 537,742 | $4.36M |
| Sectoral Asset Management Inc | 27,000 | $219.0K |
| Jane Street Group, LLC | 24,192 | $196.0K |
| Quantitative Systematic Strategies LLC | 22,474 | $182.0K |
| LPL Financial LLC | 15,000 | $122.0K |
| Point72 Hong Kong Ltd | 1,508 | $12.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 123 | $1.00K |
| US Bancorp | 61 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Cogent Biosciences, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Wexford Capital LP | 20,000 | $162.0K |